How much does Seleniso cost per box?
Selinexor, a targeted therapy drug for relapsed and refractory multiple myeloma and other hematological cancers, relies on its unique mechanism of action, which inhibits the function of XPO1 (Exportin 1) protein and interferes with protein transport between the nucleus and cytoplasm, effectively curbing the proliferation and growth of cancer cells. For those patients who do not respond to traditional chemotherapy, immunotherapy, etc., Selinisol undoubtedly provides a new treatment dawn.
In China, Seleniso has been successfully launched and included in the medical insurance system. The market price is roughly between 5,000 yuan and more than 10,000 yuan per box, but the specific price will fluctuate depending on the region and hospital. In order to reduce the financial burden on patients, patients in many areas can reduce the cost of purchasing drugs through medical insurance reimbursement. In response to the problem of high drug prices, patients are advised to consult the hospital pharmacy for detailed costs and reimbursement status according to the medical insurance policy in their region, so as to better plan treatment costs.
Compared with domestic prices, the price of selinexol abroad is relatively affordable, especially the generic drugs in countries such as Laos, which cost about more than 2,000 yuan per box, which is much lower than the domestic original drugs. The ingredients of these generic drugs are basically the same as those of domestic imported drugs, and the clinical effects are also quite similar. For patients with limited financial conditions, purchasing foreign generic drugs through formal channels has become a more economical option. However, when purchasing generic drugs, it is important for patients to ensure the legality and quality of the drug so as not to pay too little for the price.
All in all, selinesol, as a targeted therapy drug, has been launched in China and included in medical insurance, bringing tangible benefits to patients. Although its price is relatively high in China, the reimbursement policy of medical insurance has reduced the financial burden of patients to a certain extent. At the same time, for patients who are considering purchasing foreign generic drugs, it is recommended to choose formal channels to ensure the quality and safety of the drugs to ensure the therapeutic effect.
xa0
Reference materials:
National Medical Products Administration (NMPA) official website. Seleniso approval information:https://www.nmpa.gov.cn
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)